Article
IDH mutation analysis in gliomas as a diagnostic and prognostic biomarker.
British journal of neurosurgery - 1 Aug 2013
Kurian K M, Haynes H R, Crosby C, Hopkins K, Williams M
Abstract excerpt
INTRODUCTION: There is a high rate of IDH1/2 mutations in low grade gliomas and in high grade gliomas deriving from them. IDH analysis of gliomas is a novel method of classification and an independent prognostic marker. We compared antibody and sequencing methods for the detection of IDH mutations. METHOD: 88 samples from 74 patients were identified. For immunohistochemistry: sections were stained with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
